Moxifloxacin Activates the SOS Response in Mycobacterium tuberculosis in a Dose- and Time-Dependent Manner
暂无分享,去创建一个
[1] Yashwant Kumar,et al. Conditional Silencing by CRISPRi Reveals the Role of DNA Gyrase in Formation of Drug-Tolerant Persister Population in Mycobacterium tuberculosis , 2019, Front. Cell. Infect. Microbiol..
[2] F. Giannoni,et al. Mycobacterium tuberculosis Is Selectively Killed by Rifampin and Rifapentine in Hypoxia at Neutral pH , 2016, Antimicrobial Agents and Chemotherapy.
[3] R. Nair,et al. De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro , 2016, Antimicrobial Agents and Chemotherapy.
[4] N. Osheroff,et al. Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: Enhancing drug activity against wild-type and resistant gyrase , 2016, Proceedings of the National Academy of Sciences.
[5] Razieh Pourahmad Jaktaji,et al. Overexpression of SOS genes in ciprofloxacin resistant Escherichia coli mutants. , 2016, Gene.
[6] M. Cox,et al. P1 Ref Endonuclease: A Molecular Mechanism for Phage-Enhanced Antibiotic Lethality , 2016, PLoS genetics.
[7] P. Genevaux,et al. Multiple Toxin-Antitoxin Systems in Mycobacterium tuberculosis , 2014, Toxins.
[8] F. Giannoni,et al. Activities of Drug Combinations against Mycobacterium tuberculosis Grown in Aerobic and Hypoxic Acidic Conditions , 2013, Antimicrobial Agents and Chemotherapy.
[9] M. Hatherill,et al. Moxifloxacin Population Pharmacokinetics in Patients with Pulmonary Tuberculosis and the Effect of Intermittent High-Dose Rifapentine , 2012, Antimicrobial Agents and Chemotherapy.
[10] S. Kaufmann,et al. Mycobacterium tuberculosis: success through dormancy. , 2012, FEMS microbiology reviews.
[11] E. Rubin,et al. Characterization and Transcriptome Analysis of Mycobacterium tuberculosis Persisters , 2011, mBio.
[12] M. Vulić,et al. Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coli , 2010, PLoS biology.
[13] M. Vulić,et al. SOS Response Induces Persistence to Fluoroquinolones in Escherichia coli , 2009, PLoS genetics.
[14] J. Hinds,et al. Mycobacterium tuberculosis DNA repair in response to subinhibitory concentrations of ciprofloxacin. , 2008, The Journal of antimicrobial chemotherapy.
[15] S. Kowalczykowski,et al. RecBCD Enzyme and the Repair of Double-Stranded DNA Breaks , 2008, Microbiology and Molecular Biology Reviews.
[16] G. Orefici,et al. Evaluation of a New Line Probe Assay for Rapid Identification of gyrA Mutations in Mycobacterium tuberculosis , 2005, Antimicrobial Agents and Chemotherapy.
[17] K. Gerdes,et al. Prokaryotic toxin–antitoxin stress response loci , 2005, Nature Reviews Microbiology.
[18] Clifton E. Barry,et al. DnaE2 Polymerase Contributes to In Vivo Survival and the Emergence of Drug Resistance in Mycobacterium tuberculosis , 2003, Cell.
[19] L. Rand,et al. Definition of the Mycobacterial SOS Box and Use To Identify LexA-Regulated Genes in Mycobacterium tuberculosis , 2002, Journal of bacteriology.
[20] F. Movahedzadeh,et al. Identification of Some DNA Damage-Inducible Genes of Mycobacterium tuberculosis: Apparent Lack of Correlation with LexA Binding , 2001, Journal of bacteriology.
[21] L. Wayne,et al. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence , 1996, Infection and immunity.